Diabetic neuropathy: clinical manifestations and current treatments

This publication has 132 references indexed in Scilit:

• Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats
  European Journal of Pharmacology, 2012
• Insulin resistance in the nervous system
  Trends in Endocrinology & Metabolism, 2012
• Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats
  European Journal of Pharmacology, 2011
• Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity
  Brain Research, 2011
• Treatment‐induced diabetic neuropathy: A reversible painful autonomic neuropathy
  Annals of Neurology, 2010
• EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
  European Journal of Neurology, 2010
• Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
  New England Journal of Medicine, 2009
• Idiopathic neuropathy patients are at high risk for metabolic syndrome
  Journal of the Neurological Sciences, 2008
• Introduction of a new incentive and target‐based contract for family physicians in the UK: good for older patients with diabetes but less good for women?
  Diabetic Medicine, 2008
• Effect of C‐Peptide on Diabetic Neuropathy in Patients with Type 1 Diabetes
  Journal of Diabetes Research, 2008